The Valley Desk

NCT01311713 · Interventional trial

Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Solid Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov